• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. Bard, Inc. (BASD) -3006260740 PowerPort ClearVUE Slim Implantable Port, ChronoFlex, 8F; Port & Catheter, Implanted, Subcutaneous, Intravascular

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. Bard, Inc. (BASD) -3006260740 PowerPort ClearVUE Slim Implantable Port, ChronoFlex, 8F; Port & Catheter, Implanted, Subcutaneous, Intravascular Back to Search Results
Catalog Number 5678300
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Rash (2033)
Date of Event 07/06/2026
Type of Reportable Event Serious Injury
Event or Problem Description
On (b)(6) 2026, a patient underwent port placement procedure using a powerport clearvue slim.Post the procedure on (b)(6) 2026, the patient observed a rash near the neck incision and beneath the port body incision in the areas where dressing tape had been applied.The patient reported that the rash was not associated with itching, redness, drainage, or swelling.The patient applied hydrocortisone cream and believed the reaction was caused by the dressing tape.The current status of the patient is unknown.
 
Event or Problem Description
On (b)(6) 2026, a patient underwent a port placement procedure using a powerport clearvue slim.Post the procedure on (b)(6) 2026, the patient observed a rash near the neck incision and beneath the port body incision in the areas where dressing tape had been applied.The patient reported that the rash was not associated with itching, redness, drainage, or swelling.The patient applied hydrocortisone cream and believed the reaction was caused by the dressing tape.There was no reported patient injury.
 
Event or Problem Description
On (b)(6) 2026, a patient underwent a port placement procedure using a powerport clearvue slim.Post procedure on (b)(6), 2026, the patient observed a rash near the neck incision and beneath the port body incision in the areas where dressing tape had been applied.The patient reported that the rash was not associated with itching, redness, drainage, or swelling.The patient applied hydrocortisone cream and believed the reaction was caused by the dressing tape.Current status of the patient is unknown.
 
Additional Manufacturer Narrative
H11: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this lot.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.The investigation is inconclusive for the reported rash issue as no objective evidence was provided for review.A review of sterilization records, endotoxin testing results, and bioburden data was conducted in accordance with applicable quality system and regulatory requirements, and no nonconformances or anomalies were identified.The definitive root cause could not be determined based upon available information.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H.4.Device manufacture date: unknown.G3, h6 (method).Section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Additional Manufacturer Narrative
H11: based on the clarification received, the rash is only a local reaction and should be classified as malfunction.The file was reassessed for reportability and determined to be reportable as malfunction.Manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this lot.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.The investigation is inconclusive for the reported rash issue as no objective evidence was provided for review.A review of sterilization records, endotoxin testing results, and bioburden data was conducted in accordance with applicable quality system and regulatory requirements, and no nonconformances or anomalies were identified.The definitive root cause could not be determined based upon available information.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.Section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Additional Manufacturer Narrative
H11: as the lot number for the device was provided, a review of the device history records will be performed.The sample has not been returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) are adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow up report will be submitted as applicable.Section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PowerPort ClearVUE Slim Implantable Port, ChronoFlex, 8F
Common Device Name
Port & Catheter, Implanted, Subcutaneous, Intravascular
Manufacturer (Section D)
C.R. Bard, Inc. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
Bard Reynosa S.A. de C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
michael gaffney
800 w. rio salado pkwy
tempe, AZ 85281
+1(480)303-2689
MDR Report Key50097615
Report Number3006260740-2026-05406
Device Sequence Number21424779
Product Code LJT
UDI-Device Identifier00801741110818
UDI-Public(01)00801741110818(17)271231(10)RELQ1432
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
K122899
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Reporter Type Manufacturer
Report Source Other,Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/22/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number5678300
Device Lot NumberRELQ1432
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/10/2026
Supplement Date Received by Manufacturer08/14/2026
09/22/2026
Initial Report FDA Received Date07/31/2026
Supplement Report FDA Received Date09/08/2026
09/24/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-